SCHEMBL312366

SCHEMBL312366

CCOC(=O)Nc1nc(O)cc(O)c1-c1cc(=O)c2ccccc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.58
HPGD P15428 6/20 0.58
LMNA P02545 3/20 0.58
HSD17B10 Q99714 3/20 0.58
TNKS O95271 4/20 0.50
CSNK2A2 P19784 3/20 0.47
CSNK2B P67870 3/20 0.47
CSNK2A1 P68400 3/20 0.47
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
RAB9A P51151 2/20 0.46
MAPT P10636 4/20 0.45
GALR3 O60755 1/20 0.45
MAOB P27338 3/20 0.45
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
FTO Q9C0B1 2/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311720 0.85 HPGD (0.59) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL312401 0.85 KDM4E (0.59) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL312706 0.82 KDM4E (0.61) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL311138 0.78 HPGD (0.58) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL311129 0.77 HPGD (0.63) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL312009 0.76 KDM4E (0.58) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL324201 0.74 HPGD (0.61) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL312214 0.74 HPGD (0.47) KDM4EHPGDLMNAHSD17B10CSNK2A2
SCHEMBL311355 0.74 AKR1B1 (0.51) KDM4EHPGDLMNAHSD17B10TNKS
SCHEMBL312875 0.74 KDM4E (0.58) KDM4EHPGDLMNAHSD17B10TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed